特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
353850

マンモグラフィの世界市場:成長率、動向および予測(2019年~2024年)

Mammography Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 110 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
マンモグラフィの世界市場:成長率、動向および予測(2019年~2024年)
出版日: 2020年08月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 110 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のマンモグラフィー市場の成長の主な要因には、乳癌の罹患率の増加、乳房画像診断の分野における技術的進歩、および乳癌のスクリーニングキャンペーンへの様々な組織からの投資などがあります。

当レポートでは、世界の市場を調査し、全体的な市場動向、製品タイプ・エンドユーザー・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

1イントロダクション

  • 調査の成果
  • 調査の前提条件
  • 調査範囲

2 調査方法

3 エグゼクティブサマリー

4 市場のダイナミクス

  • 市場概況
  • 市場の成長要因
    • 乳癌の罹患率の増加
    • 乳房画像診断分野における技術の進歩
    • 乳癌検診キャンペーンへの様々な組織からの投資
  • 市場の阻害要因
    • 放射線被曝による悪影響のリスク
    • 医療費償還の減少
  • ポーターのファイブフォース分析
    • 新規参入者の脅威
    • 買い手/消費者の交渉力
    • 売り手の交渉力
    • 代替製品の脅威
    • 業界内の競合の激しさ

5 市場のセグメンテーション

  • 製品タイプ別
    • デジタルシステム
    • アナログシステム
    • 乳房トモシンセシス
    • フィルムスクリーンシステム
    • 他の製品タイプ
  • エンドユーザー別
    • 病院
    • 専門クリニック
    • 診断センター
  • 地域
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

6 競合情勢

  • 企業プロファイル
    • アナログ株式会社
    • キヤノンメディカルシステムズ
    • 富士フイルム
    • GE Healthcare
    • GENERAL MEDICAL MERATE (GMM)
    • Hologic Inc.
    • Koninklijke Philips NV
    • Metaltronica SpA
    • PLANMED OY
    • Siemens Healthineers

7 市場機会および将来動向

目次
Product Code: 51544

The major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns.

  • According to the Centers for Disease Control and Prevention (CDC) reports, breast cancer is one of the most common cancers among women, irrespective of race or ethnicity. It is also the third most common cause of death from cancer among American Indian/Alaska Native women.
  • According to the estimates of the Globocan, there were 2,088,849 new cases of breast cancer in 2018. Furthermore, as the global population is aging, a large number of women are expected to move into the 60 and above age category. Women aged 60 years and above account for almost 78% of all breast cancer-related deaths. High-incidence and mortality rates for breast cancer in this age group represent a huge unmet need for breast cancer diagnostics. As the number of incidents and mortality cases is increasing, the demand for mammography is also expected to increase. This remains a major driver for the mammography market and is expected to boost the market during the forecast period.

Key Market Trends

The Digital Mammography Segment is Expected to Account for the Largest Market Share During the Forecast Period

Digital mammography is a specialized and advanced form of mammography that uses digital receptors and computers instead of X-ray films to examine breast tissue for the presence of tumors. So far, conventional screen-film mammography (SFM) with high-spatial resolution has been the preferred choice for screening programs in most countries. However, with the advent of digital mammography, an increasing number of countries are experiencing shifts toward these newer systems, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. They also come with an added advantage of soft-copy image displays and soft-copy reading, which can be easily transferred. Mammography screening in various countries, such as in the United Kingdom, is now digital, which offers greater precision, better quality, and higher efficiency. Thus, digital mammography is becoming the preferred choice of screening, even though the cost of the new technology is six times higher than the conventional systems. Radiation exposure is significantly lower as compared to analog systems. Full-field digital mammography is the most common form of digital mammography employed. It offers the potential for significant advances in breast cancer diagnosis, including lower radiation dosages, reduced breast compression pressure, and improved detection. All these advantages aid in the growth of the market over the forecast period.

North America Accounts for the Largest Share in the Global Market

North America is found to hold a major share for the mammography market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The rising prevalence of breast cancer and the presence of better healthcare infrastructure in the region are expected to drive the overall growth of the market over the forecast period.

As per the estimates of Breastcancer.org, an estimated 268,600 new cases of invasive breast cancer were diagnosed in women in the United States in 2019. Furthermore, there is a rise in funding activity for research in breast cancer. For instance, according to the NCI budget factbook, breast cancer received funding of USD 545.1 million in 2017. In the United States, the National Breast Cancer Foundation (NBCF) is the organization that provides breast cancer education and free mammograms to women in need. This organization conducts various programs, such as National Mammography Program, Beyond The Shock, Patient Navigation, and Breast Health Awareness. Thus, owing to the rising prevalence of breast cancer and awareness among the population, the market is expected to experience growth over the forecast period.

Competitive Landscape

The mammography market is a consolidated one, owing to the presence of a few major players in the market. The major market players are focusing on technological advancements and reducing the side effects of the procedures. Some of the major players in the market are Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips NV, and Siemens Healthineers.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of Breast Cancer
    • 4.2.2 Technological Advancements in the Field of Breast Imaging
    • 4.2.3 Investment from Various Organizations in Breast Cancer Screening Campaigns
  • 4.3 Market Restraints
    • 4.3.1 Risk of Adverse Effects from Radiation Exposure
    • 4.3.2 Reduction in Reimbursement
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Digital Systems
    • 5.1.2 Analog Systems
    • 5.1.3 Breast Tomosynthesis
    • 5.1.4 Film Screen Systems
    • 5.1.5 Other Product Types
  • 5.2 By End Users
    • 5.2.1 Hospitals
    • 5.2.2 Specialty Clinics
    • 5.2.3 Diagnostic Centers
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Fujifilm Holdings Corporation
    • 6.1.2 GE Healthcare
    • 6.1.3 Hologic Inc.
    • 6.1.4 GENERAL MEDICAL MERATE SpA
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 Metaltronica SpA
    • 6.1.7 Konica Minolta Inc.
    • 6.1.8 Planmed Oy
    • 6.1.9 Siemens Healthineers
    • 6.1.10 Carestream Health

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.